As the number of infections in the U.S. is rapidly increasing at a record number due to the novel coronavirus infection (COVID-19) Omicron mutation, the U.S. health authorities are considering a plan to advance the booster shot vaccination standard from six months to five months. passed on
The New York Times (NYT) reported this on the 30th (local time) citing a source familiar with the deliberation of health authorities such as the US Food and Drug Administration (FDA).
The FDA is currently reviewing a plan to advance the Pfizer vaccine booster shot to ‘5 months’ after the second dose of the vaccine, which can be given ‘6 months’ after the second dose of the vaccine for both adolescents and adults.
In addition, from January 3, next year, children between the ages of 12 and 15 will receive the Pfizer vaccine booster shot.
In addition, it is expected that the BoosterShot vaccine will be approved for children aged 5 to 11 years with immune system problems.
The Centers for Disease Control and Prevention (CDC) advisory committee will hold a meeting by the middle of next week to decide whether to recommend changes or not. If the advisory committee agrees to the FDA approval, CDC Director Rochelle Wallensky is likely to approve the amendments quickly, the New York Times reported.
As such, the U.S. health authorities’ plan to expand the target of booster shot is that the highly contagious omicron mutation causes about 500,000 COVID-19 cases a day, putting more pressure on the hospital system, which has already reached its limit with patients due to the delta mutation. The NYT analyzed that it is because
According to the CDC, more than 70% of the U.S. population over the age of 12 are now vaccinated. At least 1.8 million adolescents between the ages of 12 and 15 have tested positive for coronavirus. Children are known to be more tolerant of coronavirus infection, but some can become seriously ill and even die.
(Washington = News 1)